Intellijoint receives FDA clearance for direct anterior approach device — 4 details Featured

Written by  Adam Schrag | Tuesday, 07 March 2017 22:21
Social sharing

Waterloo, Ontario-based Intellijoint Surgical received FDA clearance for the intellijoint HIP Anterior, the newest addition to the company's intellijoint HIP suite.

Here are four things to know:


1. The 3D mini-optical navigation device provides measurements for cup position, leg length and offset to surgeons performing direct anterior approach total hip arthroplasty.


2. Intelligjoint Surgical scientific advisory board member Javad Parvizi, MD, of Philadelphia-based Thomas Jefferson University Hospital's department of orthopedic surgery says, "intellijoint HIP Anterior has been developed by a group of brilliant engineers with deep understanding of the steps involved in direct anterior hip replacement, which allows surgeons to integrate the device easily into their workflow."


3. Intellijoint HIP Anterior underwent 20 FDA-cleared simulations to measure anteversion and inclination, accurately measuring them to within 0.47 degrees and 0.65 degrees, respectively, when compared compared to radiographic scans.


4. The device offers cup position measurements for supine coronal plane or anterior pelvic plane, depending on a surgeon's preference.


More device articles:
Vertebral Technologies goes global

How Supreme Court nominee Neil Gorsuch could help medical device companies — 5 notes

GOP healthcare plan to kill medical device tax — 5 observations

Last modified on Wednesday, 08 March 2017 13:49
© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months